0001140361-16-055143.txt : 20160226 0001140361-16-055143.hdr.sgml : 20160226 20160226154008 ACCESSION NUMBER: 0001140361-16-055143 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160226 DATE AS OF CHANGE: 20160226 EFFECTIVENESS DATE: 20160226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALZHEON, INC. CENTRAL INDEX KEY: 0001582636 IRS NUMBER: 463074149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-258200 FILM NUMBER: 161461265 BUSINESS ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 857-214-7242 MAIL ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0707 D LIVE 0001582636 ALZHEON, INC. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 508-861-7709 DELAWARE None None Corporation true 2013 David Nikodem 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Scott Minick 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Martin Tolar 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Director Franz Hefti 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Dennis Langer 111 Speen St Suite 306 Framingham MA MASSACHUSETTS 01701 Director Jean-Pierre Garnier 111 Speen St Suite 306 Framingham MA MASSACHUSETTS 01701 Director Ken Mace 111 Speen St Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Biotechnology Decline to Disclose 06b false 2016-02-04 false true true false 0 CIM Securities, LLC 120852 None None 509 Madison Ave Suite 1006 New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO FL FLORIDA IL ILLINOIS MA MASSACHUSETTS MD MARYLAND NY NEW YORK TX TEXAS WY WYOMING false 5000000 1300000 3700000 false 3 78000 0 0 false ALZHEON, INC. /s/ Martin Tolar Martin Tolar Chief Executive Officer 2016-02-26